1. Kal HB, Struikmans H. Radiotherapy during pregnancy:
fact and fiction. Lancet Oncol 2005; 6: 328-333.
2. Tewari KS. Cancer in pregnancy. In: DiSaia PJ,
Creasman WT, eds. Clinical Gynecologic Oncology.
7th ed. Mosby: Elsevier; 2007: 468-531.
3. Pavlidis NA. Coexistence of pregnancy and malignancy.
Oncologist 2002; 7: 279- 287.
4. Hall EJ, Giaccia AJ. Effects of radiation on the embryo
and fetus. Radiobiology for the radiologist. 6th ed.
Philadelphia: Lippincott; 2006; 168-180.
5. Pereg D, Koren G, Lishner M. The treatment of
Hodgkin’s and non-Hodgkin’s lymhoma in pregnancy.
Haematologica 2007; 92: 1230-1237.
6. Hoppe RT. Hodgkin’s disease. In: Perez CA, Brady
LW, Halperin EC, Schmidt-Ullrich RK, eds. Principles
and practice of Radiation Oncology. 4th ed.
Philadelphia: Lippincott Williams and Wilkins; 2004:
2043-2063.
7. Diehl V, Brillant C, Engert A, et al. HD10: Investigating
reduction of combined modality treatment intensity in
early stage Hodgkin’s lymphoma. Interim analysis of a
randomized trial of the German Hodgkin Study Group
(GHSG). J Clin Oncol (Meeting Abstracts) 2005; 23:
6506.
8. Woo SY, Fuller LM, Cundiff JH, et al. Radiotherapy
during pregnancy for clinical stages IA-IIA Hodgkin’s
disease. Int J Radiat.Oncol Biol Phys. 1992; 23: 407-
412.
9. Nuyttens JJ, Prado KL, Jenrette JM, Williams TE. Fetal
dose during radiotherapy: clinical implementation and
review of the literature. Cancer Radiother 2002; 6:
352-357.
10. Zucali R, Marchesini R, De Palo G. Abdominal
dosimetry for supradiaphragmatic irradiation of
Hodgkin’s disease in pregnancy: experimental data
and clinical consideration. Tumori 1981; 67: 203-208.
11. Nisce LZ, Tome MA, He S, et al. Management of coexisting
Hodgkin’s disease and pregnancy. Am J Clin
Oncol 1986; 9: 146-151.
12. Mazonakis M, Varveris H, Fasoulaki M, Damilakis J.
Radiotherapy of Hodgkin’s disease in early pregnancy:
embryo dose measurements. Radiother Oncol 2003;
66: 333-339.
13. Cygler J, Ding GX, Kendal W, Cross P. Fetal dose for a
patient undergoing mantle field irradiation for
Hodgkin’s disease. Med Dosim 1997; 22: 135-137.
14. International Commission on Radiological Protection.
Pregnancy and medical radiation. Ann ICRP 2000; 30:
1-43.
15. International Commission on Radiological Protection.
Biological effects after prenatal irradiation(embryo and
fetus). Ann ICRP 2003; 33: 205-206.
16. Hammer-Jacobsen E. Therapeutic abortion on account
X-ray examination during pregnancy. Dan Med Bull
1959; 6: 113-122.
17. Wagner LK, Lester RG, Saldana LR. Exposure of the
pregnant patient to diagnostic radiations. 2nd ed.
Madison, Wisconsin: Medical Physics Publishing;
1997.
18. Stovall M, Blackwell CR, Cundiff J, Novack DH, et al.
Fetal dose from radiotherapy with photon beams:
Report of AAPM Radiation Therapy Committee Task
Group no: 36. Med Phys 1995; 22: 63-82.
19. Lishner M, Zemlickis D, Degendorfer P, et al. Maternal
and fetal outcome following Hodgkin’s disease in
pregnancy. Br J Cancer 1992; 65: 114-117.
20. Sneed PK, Albright NW, War WM, et al. Fetal dose estimates
for radiotherapy of brain tumors during pregnancy.
Int J Radiat Oncol Biol Phys 1995; 32: 823-830.
21. Antypas C, Sandilos P, Kouvaris J, et al. Fetal dose
evaluation during breast cancer radiotherapy. Int J
Radiat Oncol Biol Phys 1998; 40: 995-999.
22. Greskovich JF, Macklis RM. Radiation therapy in pregnancy:
risk calculation and risk minimization.
Seminars in Oncology 2000; 27: 633-645.
23. Ioachim HL. Non-Hodgkin’s lymphoma in pregnancy:
three cases and review of the literature. Arch Pathol
Lab Med 1985; 109: 803-809.
